ANKTIVA vs PADCEV

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 21, 2026·How we rate

Possible drug interaction. ANKTIVA and PADCEV are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	ANKTIVA	PADCEV
Rating	New	72/100
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	nogapendekin alfa inbakicept-pmln	ENFORTUMAB VEDOTIN-EJFV
Manufacturer	Altor Bioscience, LLC, An Indirect Wholly-Owned Su	Astellas
Dosage forms	Solution	Injectable
Drug class	Interleukin-15 Receptor Agonist	—
Boxed warning	None	Boxed warning
Treats	Urinary Bladder Neoplasms	Urinary Bladder Neoplasms

anktiva padcev

Rating

New

72/100

Pharmacy pays

—

Type

Active ingredient

nogapendekin alfa inbakicept-pmln

ENFORTUMAB VEDOTIN-EJFV

Manufacturer

Altor Bioscience, LLC, An Indirect Wholly-Owned Su

Astellas

Dosage forms

Solution

Injectable

Drug class

Interleukin-15 Receptor Agonist

—

Boxed warning

None

Boxed warning

Treats

Urinary Bladder Neoplasms

Frequently asked questions

What is the difference between Anktiva and Padcev?

Anktiva contains Nogapendekin Alfa Inbakicept-Pmln, while Padcev contains Enfortumab Vedotin-Ejfv — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.